LPL Financial’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIB
HF
TFA
SBIA
SW
CIA
TI
LPL Financial's BIB Position: Q1 2020 in Review
LPL Financial sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2020, closing a stake of 3,660 shares — an estimated $226K sold.
LPL Financial first reported a position in BIB in Q2 2013 and held it in 19 quarters. The position peaked at $2.51M in Q4 2015. 26 funds tracked by Wall St. Rank hold BIB as of Q1 2020.
- LPL Financial reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
- LPL Financial sold 3,660 ProShares Ultra NASDAQ Biotechnology shares in Q1 2020, an estimated $226K.
- LPL Financial first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2013 and held it in 19 quarters.
- LPL Financial's ProShares Ultra NASDAQ Biotechnology position peaked at $2.51M in Q4 2015.
- 26 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2020.
Based on LPL Financial's 13F filing for Q1 2020, filed 14 May 2020.